Clinical trial
Multifocal Electrophysiologic Findings After Intravitreal Bevacizumab(Avastin)Treatment
NCT00417833 is registered in ClinicalTrials.gov with Asociación para Evitar la Ceguera en México as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Multifocal Electrophysiologic Findings After Intravitreal Bevacizumab(Avastin)Treatment
- Lead sponsor
- Asociación para Evitar la Ceguera en México
- Phase
- Phase 2/3
- Overall status
- Terminated
- Start date
- December 31, 2005
- Completion date
- July 31, 2006
- Enrollment
- Not reported
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
choroidal neovascularization, diabetic proliferative retinopathy, vascular vein oclussion